Skip to main content
Clinical Trials/NCT03941925
NCT03941925
Unknown
Not Applicable

Double-blind, Randomized Placebo-controlled Trial Investigating the Effect of Prebiotic Fructans on Bowel Habits of Constipated Young Children One to Three Years of Age

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 site in 1 country100 target enrollmentJuly 1, 2019
ConditionsConstipation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Constipation
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Enrollment
100
Locations
1
Primary Endpoint
Stool consistency
Last Updated
4 years ago

Overview

Brief Summary

The aim of the study is to confirm the effectiveness of chicory-derived prebiotic inulin-type fructans on bowel function in young children.

Detailed Description

The aim of the study is to confirm the effectiveness of chicory-derived prebiotic inulin-type fructans on bowel function in young children. It is a double-blind, randomized, placebo-controlled trial.This study plans to recruit into the group of 100 participants (at least 80 of them completed) in 2018-2020.The two groups for the study are product group (prebiotic fructans) and control group (placebo maltodextrin).Duration of intervention is 6 weeks, including 2 weeks for run-in and 4 weeks for intervention.Efficacy parameters are stool consistency (assessed with Amsterdam infant stool scale),stool frequency, stool amount and stool color (assessed with Amsterdam infant stool scale, treatment success, tolerance and acceptability).

Registry
clinicaltrials.gov
Start Date
July 1, 2019
End Date
December 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of functional constipation following ROME4 criteria.
  • Subject is otherwise healthy at the time of pre-examination.
  • Subject is aged 1-3 years at the time of pre-examination.
  • Subject and caretaker are able and willing to follow the study instructions.
  • Subject is suitable for participation in the study according to the investigator/physician/study personnel.
  • Written informed consent is given by parent or legal guardian.

Exclusion Criteria

  • No legal guardian's command of any local language.
  • Organic causes of defecation disorders incl. Hirschsprung disease, Spina bifida, hypothyroidism etc.
  • Other metabolic or renal abnormalities or mental retardation (Child's mental delay).
  • Food allergies or intolerances.
  • Using drugs (e.g. antibiotics) influencing gastrointestinal function (4 weeks before run-in, 6 weeks before intervention).
  • Use of laxatives and labelled pre- and probiotics in the previous 2 weeks before the beginning of run-in (4 weeks before intervention)
  • Subjects who are currently involved or will be involved in another clinical or food study

Outcomes

Primary Outcomes

Stool consistency

Time Frame: 4 weeks

Assessed by the parents in a continuous daily bowel diary over the study period using the Amsterdam Infant Stool Scale (AISS) comprised of a 4-point scale (A: watery, B: soft, C: formed, D: hard)

Secondary Outcomes

  • Stool amount and stool colour(4 weeks)
  • Treatment success(4 weeks)
  • Faecal microbiota(4 weeks)
  • Stool frequency(4 weeks)
  • Faecal Short Chain Fatty Acids concentration(4 weeks)
  • Faecal pH(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials